|

Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

RECRUITINGSponsored by University of Colorado, Denver
Actively Recruiting
SponsorUniversity of Colorado, Denver
Started2022-02-04
Est. completion2025-04-30
Eligibility
Age6 Years – 25 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06546943

Summary

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).

Eligibility

Age: 6 Years – 25 YearsHealthy volunteers accepted
Inclusion Criteria:

* 6- 25 years old
* Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
* access to a smart phone and/or internet connection and the ability to complete remote telehealth visits

Exclusion Criteria:

* known type 1 or type 2 diabetes, monogenic diabetes
* critical illness requiring admission to the ICU
* pregnancy

Conditions2

Cystic Fibrosis Pulmonary ExacerbationDiabetes

Locations1 site

Children's Hospital Colorado, University of Colorado Denver
Aurora, Colorado, 80045
Christine Hovater, BS720-777-3286christine.hovater@childrenscolorado.org

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.